Skip to main content

The Essential

Are Institutions Funding AI Abundance or Catastrophe?

Every dollar backing the AI buildout is a wager that AI will deliver extraordinary gains rather than disaster. Asset owners are in on that bet, whether they realize it or not.

Private Credit Forum - Texas

November 9-10, 2026 | Hotel ZaZa Austin Downtown

Gulf Credit Is More Liquid Than You Think

Electronic trading and rising turnover are helping make Gulf credit more liquid than its reputation suggests.

Sponsored

From Equitizing Cash to Core Holdings: How Asset Owners are Rethinking ETFs

Is the S&P 500's Concentrated Rally Starting to Diversify?

2026 Hedge Fund Roundtable | The AI Opportunity Through a Hedge Fund Lens

AI Drug Discovery Reaches the IPO Market

Iambic Therapeutics, backed by Coatue, Nvidia, Millennium, and Two Sigma, is bringing its AI-based drug development to public investors.

Related Content

Opinion: The AI Diligence Question Every Asset Owner Should Be Asking

Angelo Calvello

AI Meets Biotech — and Hedge Funds Are Buying In

Stephen Taub

The Art — and Imperfection — of Due Diligence

Christopher Schelling

SPONSORED BY CME GROUP

II Communities on Global Markets

Events and Ideas Shaping Today’s Global Markets

Why Flat Gold During Inflation Points to Fed Action

Gold is often viewed as a hedge against inflation. Why is it trading mostly sideways, even as inflation remains above target?

What Past Sector Concentrations Tell Us About Today's Tech-Heavy S&P 500

The "broad market" benchmark and the tech benchmark are nearly identical in how they move. Is the S&P 500 quietly becoming a tech index?

Job Board – For Investors Only

Investment Analyst

​

University of Virginia

​
Learn More

Investment Analyst

​

DUMAC Inc

​
Learn More

Investment Analyst

​

DUMAC Inc

​
Learn More

Investment Analyst

​

BlueCross BlueShield Association

​
Learn More

1270 Avenue of the Americas, Suite 1120

New York, NY 10020

 

© Institutional Investor, LLC. All material subject to strictly enforced copyright laws. Please read our Terms and Conditions and Privacy Policy before using the site. Institutional Investor is part of Delinian.

 

| Unsubscribe

LinkedIn
X
Bluesky
Instagram